<table id="table8" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 8:	Effect of Efavirenz on Coadministered Drug Plasma C<sub>max</sub>,
AUC, and C<sub>min</sub>
</caption>
<col width="12%"></col>
<col width="20%"></col>
<col width="20%"></col>
<col width="5%"></col>
<col width="14%"></col>
<col width="15%"></col>
<col width="14%"></col>
<thead>
<tr>
<th align="left" rowspan="2" stylecode="Toprule" valign="bottom">
<content stylecode="bold">Coadministered
Drug</content>
</th>
<th align="center" rowspan="2" stylecode="Toprule" valign="bottom">
<content stylecode="bold">Dose</content>
</th>
<th align="center" rowspan="2" stylecode="Toprule" valign="bottom">
<content stylecode="bold">Efavirenz
Dose</content>
</th>
<th rowspan="2" stylecode="Toprule" valign="bottom">
<content stylecode="bold">Number of Subjects</content>
</th>
<th align="center" colspan="3" rowspan="1" stylecode="Toprule Botrule">
<content stylecode="bold">Coadministered
Drug<br/>(mean % change)</content>
</th>
</tr>
<tr valign="bottom">
<th align="center" colspan="1" rowspan="1" stylecode="Toprule">
<content stylecode="bold">C<sub>max</sub>
<br/>(90%
CI)</content>
</th>
<th align="center" colspan="1" rowspan="1" stylecode="Toprule">
<content stylecode="bold">AUC<br/>(90%
CI)</content>
</th>
<th align="center" colspan="1" rowspan="1" stylecode="Toprule">
<content stylecode="bold">C<sub>min</sub>
<br/>(90%
CI)</content>
</th>
</tr>
</thead>
<tfoot>
<tr>
<td align="left" colspan="7">↑ Indicates increase    ↓ Indicates decrease   ↔  Indicates no change or a mean increase or decrease of &lt;10%.</td>
</tr>
<tr>
<td colspan="7">
<sup>a</sup>  Compared with atazanavir 400
mg qd alone.</td>
</tr>
<tr>
<td colspan="7">
<sup>b</sup>  Comparator dose of indinavir
was 800 mg q8h x 10 days.</td>
</tr>
<tr>
<td colspan="7">
<sup>c</sup>  Parallel-group design; n for
efavirenz + lopinavir/ritonavir, n for lopinavir/ritonavir alone.</td>
</tr>
<tr>
<td colspan="7">
<sup>d</sup>  Values are for lopinavir;
the pharmacokinetics of ritonavir in this study were unaffected by concurrent
efavirenz.</td>
</tr>
<tr>
<td colspan="7">
<sup>e</sup> 95% CI.</td>
</tr>
<tr>
<td colspan="7">
<sup>f</sup>  Soft Gelatin Capsule.</td>
</tr>
<tr>
<td colspan="7">
<sup>g</sup>  Tenofovir disoproxil fumarate.</td>
</tr>
<tr>
<td colspan="7">
<sup>h</sup>  90% CI not available.</td>
</tr>
<tr>
<td colspan="7">
<sup>i</sup>  Relative to steady-state administration
of voriconazole (400 mg for 1 day, then 200 mg po q12h for 2 days).</td>
</tr>
<tr>
<td align="left" colspan="7">
<sup>j</sup>  Not available because
of insufficient data.</td>
</tr>
<tr>
<td colspan="7">NA = not available.</td>
</tr>
</tfoot>
<tbody>
<tr>
<td colspan="1" rowspan="1" stylecode="Toprule" valign="top">Atazanavir</td>
<td colspan="1" rowspan="1" stylecode="Toprule" valign="top">400 mg qd with a
light meal d 1‑20</td>
<td colspan="1" rowspan="1" stylecode="Toprule" valign="top">600 mg qd with a
light meal d 7‑20</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule" valign="top">27</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule" valign="top">↓ 59%<br/>(49-67%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule" valign="top">↓ 74%<br/>(68-78%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule" valign="top">↓ 93%<br/>(90-95%)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> </td>
<td colspan="1" rowspan="1" valign="top">400 mg qd d 1‑6, then 300 mg qd d 7‑20 with ritonavir 100 mg qd and a light meal</td>
<td colspan="1" rowspan="1" valign="top">600 mg qd 2 h after atazanavir and
ritonavir d 7‑20</td>
<td align="center" colspan="1" rowspan="1" valign="top">13</td>
<td align="center" colspan="1" rowspan="1" valign="top">↑ 14%<sup>a</sup>
<br/>(↓ 17-↑ 58%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">↑ 39%<sup>a</sup>
<br/>(2-88%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">↑ 48%<sup>a</sup>
<br/>(24-76%)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> </td>
<td colspan="1" rowspan="1" valign="top">300 mg qd/ritonavir 100 mg qd d 1‑10 (pm), then 400 mg qd/ritonavir 100 mg qd d 11‑24 (pm) (simultaneous with efavirenz)</td>
<td colspan="1" rowspan="1" valign="top">600 mg qd with a light snack d 11‑24 (pm)</td>
<td align="center" colspan="1" rowspan="1" valign="top">14</td>
<td align="center" colspan="1" rowspan="1" valign="top">↑ 17%<br/>(8-27%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">↔</td>
<td align="center" colspan="1" rowspan="1" valign="top">↓ 42%
														<br/>(31-51%)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" stylecode="Toprule" valign="top">Indinavir</td>
<td colspan="1" rowspan="1" stylecode="Toprule">1000 mg q8h x 10 days</td>
<td colspan="1" rowspan="1" stylecode="Toprule">600 mg qd x 10 days</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">20</td>
<td align="left" colspan="3" rowspan="1" stylecode="Toprule"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td colspan="3" rowspan="1" valign="top">After morning dose</td>
<td align="center" colspan="1" rowspan="1" valign="top">↔<sup>b</sup>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">↓ 33%<sup>b</sup>
<br/>(26-39%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">↓ 39%<sup>b</sup>
<br/>(24-51%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td colspan="3" rowspan="1" valign="top">After afternoon dose</td>
<td align="center" colspan="1" rowspan="1" valign="top">↔<sup>b</sup>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">↓ 37%<sup>b</sup>
<br/>(26-46%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">↓ 52%<sup>b</sup>
<br/>(47-57%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td colspan="3" rowspan="1" valign="top">After evening dose</td>
<td align="center" colspan="1" rowspan="1" valign="top">↓ 29%<sup>b</sup>
<br/>(11-43%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">↓ 46%<sup>b</sup>
<br/>(37-54%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">↓ 57%<sup>b</sup>
<br/>(50-63%)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1" stylecode="Toprule">Lopinavir/<br/>   ritonavir</td>
<td colspan="1" rowspan="1" stylecode="Toprule">400/100 mg capsule<br/>q12h
x 9 days</td>
<td colspan="1" rowspan="1" stylecode="Toprule">600 mg qd x 9 days</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">11,7<sup>c</sup>
</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↔<sup>d</sup>
</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 19%<sup>d</sup>
<br/>(↓ 36-↑ 3%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 39%<sup>d</sup>
<br/>(3-62%)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> </td>
<td colspan="1" rowspan="1" valign="top">600/150 mg tablet<br/>q12h
x 10 days with<br/>efavirenz compared to<br/>400/100 mg q12h
alone</td>
<td colspan="1" rowspan="1" valign="top">600 mg qd x 9 days</td>
<td align="center" colspan="1" rowspan="1" valign="top">23</td>
<td align="center" colspan="1" rowspan="1" valign="top">↑ 36%<sup>d</sup>
<br/>(28-44%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">↑ 36%<sup>d</sup>
<br/>(28-44%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">↑ 32%<sup>d</sup>
<br/>(21-44%)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1" stylecode="Toprule">Nelfinavir</td>
<td colspan="1" rowspan="1" stylecode="Toprule">750 mg q8h x 7 days</td>
<td colspan="1" rowspan="1" stylecode="Toprule">600 mg qd x 7 days</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">10</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↑ 21%<br/>(10-33%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↑ 20%<br/>(8-34%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↔</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">   Metabolite<br/>      AG-1402</td>
<td colspan="3" rowspan="1"> </td>
<td align="center" colspan="1" rowspan="1">↓ 40%<br/>(30-48%)</td>
<td align="center" colspan="1" rowspan="1">↓ 37%<br/>(25-48%)</td>
<td align="center" colspan="1" rowspan="1">↓ 43%<br/>(21-59%)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1" stylecode="Toprule">Ritonavir</td>
<td colspan="1" rowspan="1" stylecode="Toprule">500 mg q12h x 8 days</td>
<td colspan="1" rowspan="1" stylecode="Toprule">600 mg qd x 10 days</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">11</td>
<td align="left" colspan="3" rowspan="1" stylecode="Toprule"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td colspan="3" valign="top">   After AM dose</td>
<td align="center" colspan="1" rowspan="1" valign="top">↑ 24%<br/>(12-38%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">↑ 18%<br/>(6-33%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">↑ 42%<br/>(9-86%)<sup>e</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td colspan="3" valign="top">   After PM dose</td>
<td align="center" colspan="1" rowspan="1" valign="top">↔</td>
<td align="center" colspan="1" rowspan="1" valign="top">↔</td>
<td align="center" colspan="1" rowspan="1" valign="top">↑ 24%<br/>(3-50%)<sup>e</sup>
</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1" stylecode="Toprule">Saquinavir<br/>   SGC<sup>f</sup>
</td>
<td colspan="1" rowspan="1" stylecode="Toprule">1200 mg q8h x 10 days</td>
<td colspan="1" rowspan="1" stylecode="Toprule">600 mg qd x 10 days</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">12</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 50%<br/>(28-66%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 62%<br/>(45-74%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 56%<br/>(16-77%)<sup>e</sup>
</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1" stylecode="Toprule">Lamivudine</td>
<td colspan="1" rowspan="1" stylecode="Toprule">150 mg q12h x 14 days</td>
<td colspan="1" rowspan="1" stylecode="Toprule">600 mg qd x 14 days</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">9</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↔</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↔</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↑ 265%<br/>(37-873%)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1" stylecode="Toprule">Tenofovir<sup>g</sup>
</td>
<td colspan="1" rowspan="1" stylecode="Toprule">300 mg qd	</td>
<td colspan="1" rowspan="1" stylecode="Toprule">600 mg qd x 14 days</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">29</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↔</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↔</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↔</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1" stylecode="Toprule">Zidovudine</td>
<td colspan="1" rowspan="1" stylecode="Toprule">300 mg q12h x 14 days</td>
<td colspan="1" rowspan="1" stylecode="Toprule">600 mg qd x 14 days</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">9</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↔</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↔</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↑ 225%<br/>(43-640%)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1" stylecode="Toprule">Maraviroc</td>
<td colspan="1" rowspan="1" stylecode="Toprule">100 mg bid</td>
<td colspan="1" rowspan="1" stylecode="Toprule">600 mg qd</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">12</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 51%<br/>(37-62%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 45%<br/>(38-51%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 45%<br/>(28-57%)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1" stylecode="Toprule">Raltegravir</td>
<td colspan="1" rowspan="1" stylecode="Toprule">400 mg single dose</td>
<td colspan="1" rowspan="1" stylecode="Toprule">600 mg qd</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">9</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 36%<br/>(2-59%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 36%<br/>(20-48%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 21%<br/>(↓ 51-↑ 28%)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1" stylecode="Toprule">Boceprevir</td>
<td colspan="1" rowspan="1" stylecode="Toprule">800 mg tid x 6 days</td>
<td colspan="1" rowspan="1" stylecode="Toprule">600 mg qd x 16 days</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">NA</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 8%<br/>(↓ 22-↑ 8%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 19%<br/>(11-25%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 44%<br/>(26-58%)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1" stylecode="Toprule">Telaprevir</td>
<td colspan="1" rowspan="1" stylecode="Toprule">750 mg q8h x 10 days</td>
<td colspan="1" rowspan="1" stylecode="Toprule">600 mg qd x 20 days</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">21</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 9%<br/>(↓ 18-↑ 2%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 26%<br/>(16-35%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 47%<br/>(35-56%)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1" stylecode="Toprule">Azithromycin</td>
<td colspan="1" rowspan="1" stylecode="Toprule">600 mg single dose</td>
<td colspan="1" rowspan="1" stylecode="Toprule">400 mg qd x 7 days</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">14</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↑ 22%<br/>(4-42%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↔</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">NA</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">Clarithromycin</td>
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">500 mg q12h x 7 days</td>
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">400 mg qd x 7 days</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">11</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 26%<br/>(15-35%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 39%<br/>(30-46%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 53%<br/>(42-63%)</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1">   14-OH metabolite</td>
<td align="left" colspan="3" rowspan="1"> </td>
<td align="center" colspan="1" rowspan="1">↑ 49%<br/>(32-69%)</td>
<td align="center" colspan="1" rowspan="1">↑ 34%<br/>(18-53%)</td>
<td align="center" colspan="1" rowspan="1">↑ 26%<br/>(9-45%)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1" stylecode="Toprule">Fluconazole</td>
<td colspan="1" rowspan="1" stylecode="Toprule">200 mg x 7 days</td>
<td colspan="1" rowspan="1" stylecode="Toprule">400 mg qd x 7 days</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">10</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↔</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↔</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↔</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1" stylecode="Toprule">Itraconazole</td>
<td colspan="1" rowspan="1" stylecode="Toprule">200 mg q12h x 28 days</td>
<td colspan="1" rowspan="1" stylecode="Toprule">600 mg qd x 14 days</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">18</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 37%<br/>(20-51%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 39%<br/>(21-53%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 44%<br/>(27-58%)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">   Hydroxy-itraconazole</td>
<td colspan="3" rowspan="1"> </td>
<td align="center" colspan="1" rowspan="1">↓ 35%<br/>(12-52%)</td>
<td align="center" colspan="1" rowspan="1">↓ 37%<br/>(14-55%)</td>
<td align="center" colspan="1" rowspan="1">↓ 43%<br/>(18-60%)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1" stylecode="Toprule">Posaconazole</td>
<td colspan="1" rowspan="1" stylecode="Toprule">400 mg (oral suspension) bid x 10 and 20 days</td>
<td colspan="1" rowspan="1" stylecode="Toprule">400 mg qd x 10 and 20 days</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">11</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 45%<br/>(34-53%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 50%<br/>(40-57%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">NA</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1" stylecode="Toprule">Rifabutin</td>
<td colspan="1" rowspan="1" stylecode="Toprule">300 mg qd x 14 days</td>
<td colspan="1" rowspan="1" stylecode="Toprule">600 mg qd x 14 days</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">9</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 32%<br/>(15-46%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 38%<br/>(28-47%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 45%<br/>(31-56%)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1" stylecode="Toprule">Voriconazole</td>
<td colspan="1" rowspan="1" stylecode="Toprule">400 mg po q12h x 1 day, then 200
mg po q12h x 8 days</td>
<td colspan="1" rowspan="1" stylecode="Toprule">400 mg qd x 9 days</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">NA</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 61%<sup>h</sup>
</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 77%<sup>h</sup>
</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">NA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1" valign="top">300 mg po q12h days 2‑7</td>
<td align="left" colspan="1" rowspan="1" valign="top">300 mg qd x 7 days</td>
<td align="center" colspan="1" rowspan="1" valign="top">	NA</td>
<td align="center" colspan="1" rowspan="1" valign="top">↓ 36%<sup>i</sup>
<br/>(21-49%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">↓ 55%<sup>i</sup>
<br/>(45-62%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">NA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1" valign="top">400 mg po q12h days 2‑7</td>
<td align="left" colspan="1" rowspan="1" valign="top">300 mg qd x 7 days</td>
<td align="center" colspan="1" rowspan="1" valign="top">NA</td>
<td align="center" colspan="1" rowspan="1" valign="top">↑ 23%<sup>i</sup>
<br/>(↓ 1-↑ 53%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">↓ 7%<sup>i</sup>
<br/>(↓ 23-↑ 13%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">NA</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">Atorvastatin</td>
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">10 mg qd x 4 days</td>
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">600 mg qd x 15 days</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">14</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 14%<br/>(1-26%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 43%<br/>(34-50%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 69%<br/>(49-81%)</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1">   Total active<br/>   (including<br/>   metabolites)</td>
<td align="left" colspan="3" rowspan="1"> </td>
<td align="center" colspan="1" rowspan="1">↓ 15%<br/>(2-26%)</td>
<td align="center" colspan="1" rowspan="1">↓ 32%<br/>(21-41%)</td>
<td align="center" colspan="1" rowspan="1">↓ 48%<br/>(23-64%)</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">Pravastatin</td>
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">40 mg qd x 4 days</td>
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">600 mg qd x 15 days</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">13</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 32%<br/>(↓ 59-↑ 12%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 44%<br/>(26-57%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 19%<br/>(0-35%)</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">Simvastatin</td>
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">40 mg qd x 4 days</td>
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">600 mg qd x 15 days</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">14</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 72%<br/>(63-79%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 68%<br/>(62-73%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 45%<br/>(20-62%)</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1">   Total active<br/>   (including<br/>   metabolites)</td>
<td align="left" colspan="3" rowspan="1"> </td>
<td align="center" colspan="1" rowspan="1">↓ 68%<br/>(55-78%)</td>
<td align="center" colspan="1" rowspan="1">↓ 60%<br/>(52-68%)</td>
<td align="center" colspan="1" rowspan="1">NA<sup>j</sup>
</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">Carbamazepine</td>
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">200 mg qd x 3 days,
200 mg bid x 3 days, then 400 mg qd x 29 days</td>
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">600 mg qd x 14 days</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">12</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 20%<br/>(15-24%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 27%<br/>(20-33%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 35%<br/>(24-44%)</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1">Epoxide metabolite</td>
<td align="left" colspan="3" rowspan="1"> </td>
<td align="center" colspan="1" rowspan="1">↔</td>
<td align="center" colspan="1" rowspan="1">↔</td>
<td align="center" colspan="1" rowspan="1">↓ 13%<br/>(↓ 30-↑ 7%)</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">Cetirizine</td>
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">10 mg single dose</td>
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">600 mg qd x 10 days</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">11</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 24%<br/>(18-30%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↔</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">NA</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">Diltiazem</td>
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">240 mg x 21 days</td>
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">600 mg qd x 14 days</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">13</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 60%<br/>(50-68%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 69%<br/>(55-79%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 63%<br/>(44-75%)</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1">   Desacetyl<br/>   diltiazem</td>
<td align="left" colspan="3" rowspan="1"> </td>
<td align="center" colspan="1" rowspan="1">↓ 64%<br/>(57-69%)</td>
<td align="center" colspan="1" rowspan="1">↓ 75%<br/>(59-84%)</td>
<td align="center" colspan="1" rowspan="1">↓ 62%<br/>(44-75%)</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1">   N-<br/>   monodesmethyl<br/>   diltiazem</td>
<td align="left" colspan="3" rowspan="1"> </td>
<td align="center" colspan="1" rowspan="1">↓ 28%<br/>(7-44%)</td>
<td align="center" colspan="1" rowspan="1">↓ 37%<br/>(17-52%)</td>
<td align="center" colspan="1" rowspan="1">↓ 37%<br/>(17-52%)</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">Ethinyl estradiol/<br/>
													   Norgestimate</td>
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">0.035 mg/<br/>0.25 mg x 14 days</td>
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">600 mg qd x 14 days</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule"></td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule"></td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule"></td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule"></td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1">   Ethinyl<br/>   estradiol</td>
<td align="left" colspan="2" rowspan="1"> </td>
<td align="center" colspan="1" rowspan="1">21</td>
<td align="center" colspan="1" rowspan="1">↔</td>
<td align="center" colspan="1" rowspan="1">↔</td>
<td align="center" colspan="1" rowspan="1">↔</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1">   Norelgestromin</td>
<td align="left" colspan="2" rowspan="1"> </td>
<td align="center" colspan="1" rowspan="1">21</td>
<td align="center" colspan="1" rowspan="1">↓ 46%<br/>(39-52%)</td>
<td align="center" colspan="1" rowspan="1">↓ 64%<br/>(62-67%)</td>
<td align="center" colspan="1" rowspan="1">↓ 82%<br/>(79-85%)</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1">   Levonorgestrel</td>
<td align="left" colspan="2" rowspan="1"> </td>
<td align="center" colspan="1" rowspan="1">6</td>
<td align="center" colspan="1" rowspan="1">↓ 80%<br/>(77-83%)</td>
<td align="center" colspan="1" rowspan="1">↓ 83%<br/>(79-87%)</td>
<td align="center" colspan="1" rowspan="1">↓ 86%<br/>(80-90%)</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">Lorazepam</td>
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">2 mg single dose</td>
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">600 mg qd x 10 days</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">12</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↑ 16%<br/>(2-32%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↔</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">NA</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">Methadone</td>
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">Stable<br/>maintenance
35-<br/>100 mg daily</td>
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">600 mg qd x 14-21 days</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">11</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 45%<br/>(25-59%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 52%<br/>(33-66%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">NA</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">Bupropion</td>
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">150 mg single dose<br/>(sustained-release)</td>
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">600 mg qd x 14 days</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">13</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 34%<br/>(21-47%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↓ 55%<br/>(48-62%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">NA</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1">   Hydroxy-<br/>   bupropion</td>
<td align="left" colspan="3" rowspan="1"> </td>
<td align="center" colspan="1" rowspan="1">↑ 50%<br/>(20-80%)</td>
<td align="center" colspan="1" rowspan="1">↔</td>
<td align="center" colspan="1" rowspan="1">NA</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1" stylecode="Toprule" valign="top">Paroxetine</td>
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">20 mg qd x 14 days</td>
<td align="left" colspan="1" rowspan="1" stylecode="Toprule">600 mg qd x 14 days</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">16</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↔</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↔</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule">↔</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1" stylecode="Toprule Botrule">Sertraline</td>
<td align="left" colspan="1" rowspan="1" stylecode="Toprule Botrule">50 mg qd x 14 days</td>
<td align="left" colspan="1" rowspan="1" stylecode="Toprule Botrule">600 mg qd x 14 days</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule Botrule">13</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule Botrule">↓ 29%<br/>(15-40%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule Botrule">↓ 39%<br/>(27-50%)</td>
<td align="center" colspan="1" rowspan="1" stylecode="Toprule Botrule">↓ 46%<br/>(31-58%)</td>
</tr>
</tbody>
</table>